Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Pakistan Journal of Pharmaceutical Sciences. 2018; 31 (6 Special): 2787-2790
em Inglês | IMEMR | ID: emr-205110

RESUMO

Hyaluronic acid [HA] is used to aid tissue repair and is a characterized inhibitor of TRPV1 channels. In this study, we investigated the effects of HA on lidocaine induced neurotoxicity and its mechanism of action. U87-MG cells with low [U87-MG-shTRPV1] or high [U87-MG-TRPV1] TRPV1 expression were studied. The control group was treated with lidocaine. The experimental group was treated with lidocaine and HA. Flow cytometry was used to assess the intracellular calcium concentration [[Ca2+] i] and cell apoptosis. Cell viability was detected by MTT assays. Compared to the control group, [Ca2+] i of U87-MG-TRPV1 and U87-MG cells were lower at T3, T4 and T5 [p < 0.05], apoptosis rates of U87-MG and U87-MG-TRPV1 cells were lower [p<0.05], and the cell viability of U87-MG and U87MG-TRPV1 cells were higher in the experimental group [p<0.05]. HA reduces the toxic damage of lidocaine through blocking Ca2+ influx through TRPV1 channels, preventing Ca2+ overload, leading to nerve cell protection

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA